Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup

Affiliations

• ¹ a Wilhelminen Cancer Research Institute, Wilhelminenspital , Vienna , Austria.
• ² b School of Medicine, National and Kapodistrian University of Athens , Athens , Greece.
• ³ c University of Nantes , Nantes , France.
• ⁴ d National University Cancer Institute, Singapore.
• ⁵ e National University Health System, Singapore.
• ⁶ f Cancer Science Institute, Singapore.
• ⁷ g National University of Singapore , Singapore.
• ⁸ h Heidelberg Medical University , Heidelberg , Germany.
• ⁹ i University Hospital Ostrava and Faculty of Medicine, University of Ostrava , Ostrava , Czech Republic.
• ¹⁰ j CHRU Lille Hôpital Claude Huriez , Lille , France.
• ¹¹ k University Hospital Brno , Brno , Czech Republic.
• ¹² l Weill Cornell Medical College/New York Presbyterian Hospital , New York , NY , USA.
• ¹³ m Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol , Barcelona , Spain.
• ¹⁴ n Hospital Clínic de Barcelona , Barcelona , Spain.
• ¹⁵ o First Republican Clinical Hospital of Udmurtia , Izhevsk , Russia.
• ¹⁶ p Department of Translational Medicine , University of Eastern Piedmont , Novara , Italy.
• ¹⁷ q University Hospital Olomouc , Olomouc , Czech Republic.
• ¹⁸ r Universitatsklinikum Tubingen , Tubingen , Germany.
• ¹⁹ s University Multiprofile Hospital for Active Treatment "Sv. Georgi" and Medical University , Plovdiv , Bulgaria.
• ²⁰ t University of Torino , Torino , Italy.
• ²¹ u Onyx Pharmaceuticals, Inc, an Amgen subsidiary , South San Francisco , CA , USA.
• ²² v Royal Prince Alfred Hospital , Camperdown , New South Wales , Australia.